JP2006515862A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515862A5 JP2006515862A5 JP2004571000A JP2004571000A JP2006515862A5 JP 2006515862 A5 JP2006515862 A5 JP 2006515862A5 JP 2004571000 A JP2004571000 A JP 2004571000A JP 2004571000 A JP2004571000 A JP 2004571000A JP 2006515862 A5 JP2006515862 A5 JP 2006515862A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- methoxy
- oxazolidine
- alkyl
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000000217 alkyl group Chemical group 0.000 claims 19
- -1 amino, piperidyl Chemical group 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 7
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000004414 alkyl thio group Chemical group 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 3
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims 3
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 125000005035 acylthio group Chemical group 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- HYUZXYZZPRBVBQ-PBHICJAKSA-N (5r)-3-[(2r)-2-hydroxy-3-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]propyl]-5-(6-methoxy-1,5-naphthyridin-4-yl)-1,3-oxazolidin-2-one Chemical compound S1CC(=O)NC2=NC(CNC[C@@H](O)CN3C[C@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 HYUZXYZZPRBVBQ-PBHICJAKSA-N 0.000 claims 1
- AQOIKSICNYLNIQ-DEOSSOPVSA-N (5r)-3-[3-(1h-indol-2-ylmethylamino)propyl]-5-(6-methoxyquinolin-4-yl)-1,3-oxazolidin-2-one Chemical compound C1=CC=C2NC(CNCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC2=C1 AQOIKSICNYLNIQ-DEOSSOPVSA-N 0.000 claims 1
- JMVHENCOUMSVSV-QFIPXVFZSA-N (5r)-3-[3-(2,1,3-benzothiadiazol-5-ylmethylamino)propyl]-5-(6-methoxyquinolin-4-yl)-1,3-oxazolidin-2-one Chemical compound C1=CC2=NSN=C2C=C1CNCCCN(C(=O)O1)C[C@H]1C1=CC=NC2=CC=C(OC)C=C21 JMVHENCOUMSVSV-QFIPXVFZSA-N 0.000 claims 1
- CBHCYXSDGUWRPT-NRFANRHFSA-N (5r)-3-[3-[(4-fluoro-1h-benzimidazol-2-yl)methylamino]propyl]-5-(6-methoxyquinolin-4-yl)-1,3-oxazolidin-2-one Chemical compound C1=CC=C2NC(CNCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=NC2=C1F CBHCYXSDGUWRPT-NRFANRHFSA-N 0.000 claims 1
- LUUOFYVQTNURRG-VWLOTQADSA-N (5r)-3-[3-[(8-hydroxyquinolin-2-yl)methyl-methylamino]propyl]-5-(6-methoxyquinolin-4-yl)-1,3-oxazolidin-2-one Chemical compound C1=CC=C(O)C2=NC(CN(C)CCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 LUUOFYVQTNURRG-VWLOTQADSA-N 0.000 claims 1
- WPDCXKPBUWDMJZ-DEOSSOPVSA-N (5r)-3-[3-[(8-hydroxyquinolin-2-yl)methylamino]propyl]-5-(6-methoxyquinolin-4-yl)-1,3-oxazolidin-2-one Chemical compound C1=CC=C(O)C2=NC(CNCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 WPDCXKPBUWDMJZ-DEOSSOPVSA-N 0.000 claims 1
- AEAOMQAWGDKZCV-VWLOTQADSA-N (5r)-3-[3-[1h-indol-2-ylmethyl(methyl)amino]propyl]-5-(6-methoxyquinolin-4-yl)-1,3-oxazolidin-2-one Chemical compound C1=CC=C2NC(CN(C)CCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC2=C1 AEAOMQAWGDKZCV-VWLOTQADSA-N 0.000 claims 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 1
- JLBIGXJQSKTBPT-UHFFFAOYSA-N 3,6-dimethyl-1,3-benzoxazol-2-one Chemical compound CC1=CC=C2N(C)C(=O)OC2=C1 JLBIGXJQSKTBPT-UHFFFAOYSA-N 0.000 claims 1
- UIRSLBDCOYTZPH-UHFFFAOYSA-N 4h-1,4-thiazin-3-one Chemical compound O=C1CSC=CN1 UIRSLBDCOYTZPH-UHFFFAOYSA-N 0.000 claims 1
- SPALLIDCFHEQEV-UHFFFAOYSA-N 5-(6-methoxy-1,5-naphthyridin-4-yl)-3-[3-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]propyl]-1,3-oxazolidin-2-one Chemical compound S1CC(=O)NC2=NC(CNCCCN3CC(OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 SPALLIDCFHEQEV-UHFFFAOYSA-N 0.000 claims 1
- UPMFSPLIDSVINY-NRFANRHFSA-N 6-[[3-[(5r)-5-(6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propylamino]methyl]-4h-pyrido[3,2-b][1,4]oxazin-3-one Chemical compound O1CC(=O)NC2=NC(CNCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 UPMFSPLIDSVINY-NRFANRHFSA-N 0.000 claims 1
- ICGMENBORXRJLF-FQEVSTJZSA-N 6-[[3-[(5r)-5-(8-fluoro-6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propylamino]methyl]-4h-pyrido[3,2-b][1,4]oxazin-3-one Chemical compound O1CC(=O)NC2=NC(CNCCCN3C[C@H](OC3=O)C3=CC=NC4=C(F)C=C(C=C43)OC)=CC=C21 ICGMENBORXRJLF-FQEVSTJZSA-N 0.000 claims 1
- AJVKFKOLEHQSPO-UHFFFAOYSA-N 6-[[3-[5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propylamino]methyl]-4h-pyrido[3,2-b][1,4]oxazin-3-one Chemical compound O1CC(=O)NC2=NC(CNCCCN3CC(OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 AJVKFKOLEHQSPO-UHFFFAOYSA-N 0.000 claims 1
- IIDSPOLGDKEOSC-FQEVSTJZSA-N 7-chloro-n-[3-[(5r)-5-(6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound N1C(=O)CSC(C=C2Cl)=C1C=C2S(=O)(=O)NCCCN(C(=O)O1)C[C@H]1C1=CC=NC2=CC=C(OC)C=C21 IIDSPOLGDKEOSC-FQEVSTJZSA-N 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000005137 alkenylsulfonyl group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000005360 alkyl sulfoxide group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 1
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 125000005361 aryl sulfoxide group Chemical group 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims 1
- 125000004468 heterocyclylthio group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- AWVYLJPUCRPLPE-UGSOOPFHSA-N n-[(2r)-2-hydroxy-3-[(5r)-5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NC[C@H](O)CN3C[C@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 AWVYLJPUCRPLPE-UGSOOPFHSA-N 0.000 claims 1
- AWVYLJPUCRPLPE-ACJLOTCBSA-N n-[(2s)-2-hydroxy-3-[(5r)-5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NC[C@@H](O)CN3C[C@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 AWVYLJPUCRPLPE-ACJLOTCBSA-N 0.000 claims 1
- POPOHMGVBQBRKI-IBGZPJMESA-N n-[3-[(5r)-5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]-2,2-dimethylpropyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NCC(C)(C)CN3C[C@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 POPOHMGVBQBRKI-IBGZPJMESA-N 0.000 claims 1
- XIPZURGTTRZAMC-SFHVURJKSA-N n-[3-[(5r)-5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 XIPZURGTTRZAMC-SFHVURJKSA-N 0.000 claims 1
- UHXYSKUHQCDLJC-IBGZPJMESA-N n-[3-[(5r)-5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzoxazine-6-sulfonamide Chemical compound O1CC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 UHXYSKUHQCDLJC-IBGZPJMESA-N 0.000 claims 1
- TZCLLMAQSGBIIS-NRFANRHFSA-N n-[3-[(5r)-5-(6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 TZCLLMAQSGBIIS-NRFANRHFSA-N 0.000 claims 1
- PCMGGFJMXBQOLU-QFIPXVFZSA-N n-[3-[(5r)-5-(6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzoxazine-6-sulfonamide Chemical compound O1CC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 PCMGGFJMXBQOLU-QFIPXVFZSA-N 0.000 claims 1
- CJJGSPROFQEUFV-IBGZPJMESA-N n-[3-[(5r)-5-(6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-pyrido[3,2-b][1,4]thiazine-6-carboxamide Chemical compound S1CC(=O)NC2=NC(C(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 CJJGSPROFQEUFV-IBGZPJMESA-N 0.000 claims 1
- BYSDKCNZAZCMBE-QFIPXVFZSA-N n-[3-[(5r)-5-(6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-4-oxo-3,5-dihydro-2h-1,5-benzothiazepine-7-sulfonamide Chemical compound S1CCC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=CC=C(C=C43)OC)=CC=C21 BYSDKCNZAZCMBE-QFIPXVFZSA-N 0.000 claims 1
- IBPIFONELNHGBT-FQEVSTJZSA-N n-[3-[(5r)-5-(8-fluoro-6-methoxyquinolin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@H](OC3=O)C3=CC=NC4=C(F)C=C(C=C43)OC)=CC=C21 IBPIFONELNHGBT-FQEVSTJZSA-N 0.000 claims 1
- XIPZURGTTRZAMC-GOSISDBHSA-N n-[3-[(5s)-5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-3-oxo-4h-1,4-benzothiazine-6-sulfonamide Chemical compound S1CC(=O)NC2=CC(S(=O)(=O)NCCCN3C[C@@H](OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 XIPZURGTTRZAMC-GOSISDBHSA-N 0.000 claims 1
- RAVATXRLPGKJOY-UHFFFAOYSA-N n-[3-[5-(6-methoxy-1,5-naphthyridin-4-yl)-2-oxo-1,3-oxazolidin-3-yl]propyl]-2,3-dihydro-1,4-benzodioxine-6-sulfonamide Chemical compound O1CCOC2=CC(S(=O)(=O)NCCCN3CC(OC3=O)C3=CC=NC4=CC=C(N=C43)OC)=CC=C21 RAVATXRLPGKJOY-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43090802P | 2002-12-04 | 2002-12-04 | |
| US46960203P | 2003-05-07 | 2003-05-07 | |
| PCT/US2003/038444 WO2004050036A2 (en) | 2002-12-04 | 2003-12-03 | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515862A JP2006515862A (ja) | 2006-06-08 |
| JP2006515862A5 true JP2006515862A5 (https=) | 2006-11-30 |
Family
ID=32474604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004571000A Ceased JP2006515862A (ja) | 2002-12-04 | 2003-12-03 | キノリン類およびそれらの窒素化誘導体ならびにそれらの抗菌剤としての使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7491714B2 (https=) |
| EP (1) | EP1567520B1 (https=) |
| JP (1) | JP2006515862A (https=) |
| AT (1) | ATE411312T1 (https=) |
| AU (1) | AU2003294565A1 (https=) |
| DE (1) | DE60324179D1 (https=) |
| ES (1) | ES2312839T3 (https=) |
| WO (1) | WO2004050036A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1470125A1 (en) | 2002-01-29 | 2004-10-27 | Glaxo Group Limited | Aminopiperidine derivatives |
| WO2003064431A2 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| TW200406413A (en) * | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| ATE479683T1 (de) | 2002-11-05 | 2010-09-15 | Glaxo Group Ltd | Antibakterielle mittel |
| DE60331849D1 (de) * | 2002-11-05 | 2010-05-06 | Glaxosmithkline Llc | Antibakterielle wirkstoffe |
| TW200427688A (en) * | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
| US7691850B2 (en) * | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
| US20070254872A1 (en) * | 2004-07-08 | 2007-11-01 | Glaxo Group Limited | Antibacterial Agents |
| US7648984B2 (en) * | 2004-07-13 | 2010-01-19 | Glaxo Group Limited | Antibacterial agents |
| CL2008001002A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| ES2380398T3 (es) * | 2007-12-18 | 2012-05-11 | Actelion Pharmaceuticals Ltd. | Derivados 5-aminociclilmetil-oxazolidin-2-ona |
| TW201309689A (zh) | 2011-02-07 | 2013-03-01 | Daiichi Sankyo Co Ltd | 含胺基之吡咯啶酮衍生物 |
| WO2014024056A1 (en) | 2012-08-06 | 2014-02-13 | Daiichi Sankyo Company, Limited | Pyrrolidine derivatives with antibacterial properties |
| CN113735770B (zh) * | 2021-09-30 | 2023-06-06 | 四川大学 | 一种铑催化的4-苯基噁二唑酮与碳酸亚乙烯酯合成1-氨基异喹啉骨架的方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19601265A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
| DE69908555T2 (de) | 1998-01-26 | 2004-05-06 | Smithkline Beecham P.L.C., Brentford | Chinolinderivate als antibakterielles arzneimittel |
| GB9822450D0 (en) | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
| GB9822440D0 (en) | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
| EP1144404A1 (en) | 1999-01-20 | 2001-10-17 | Smithkline Beecham Plc | Piperidinylquinolines as protein tyrosine kinase inhibitors |
| GB9914486D0 (en) * | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| GB9917408D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| FR2798656B1 (fr) | 1999-09-17 | 2004-12-17 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| US6403610B1 (en) * | 1999-09-17 | 2002-06-11 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
| US6762200B2 (en) * | 2000-03-28 | 2004-07-13 | Nippon Soda Co. Ltd. | Oxa(thia)zolidine derivative and anti-inflammatory drug |
| CZ2003243A3 (cs) * | 2000-07-26 | 2003-09-17 | Smithkline Beecham P. L. C. | Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou |
| EP1719770A3 (en) | 2000-09-21 | 2008-03-05 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
| FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
| US6603005B2 (en) * | 2000-11-15 | 2003-08-05 | Aventis Pharma S.A. | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
| GB0031088D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
| GB0031086D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
| ES2256331T3 (es) | 2000-12-21 | 2006-07-16 | PHARMACIA & UPJOHN COMPANY LLC | Derivados de quinolina antimicrobianos y uso de los mismos para tratar infecciones bacterianas. |
| GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| WO2003064431A2 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| EP1470125A1 (en) | 2002-01-29 | 2004-10-27 | Glaxo Group Limited | Aminopiperidine derivatives |
| AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| TW200406413A (en) * | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| GB0217294D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
| WO2004035569A2 (de) | 2002-10-10 | 2004-04-29 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue verbindungen mit antibakterieller aktivität |
| ATE479683T1 (de) | 2002-11-05 | 2010-09-15 | Glaxo Group Ltd | Antibakterielle mittel |
| DE60331849D1 (de) * | 2002-11-05 | 2010-05-06 | Glaxosmithkline Llc | Antibakterielle wirkstoffe |
| TW200427688A (en) * | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
| TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
| FR2852954B1 (fr) | 2003-03-28 | 2006-07-14 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
| US7232833B2 (en) * | 2003-03-28 | 2007-06-19 | Novexel | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| DE10316081A1 (de) | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
-
2003
- 2003-12-03 AU AU2003294565A patent/AU2003294565A1/en not_active Abandoned
- 2003-12-03 JP JP2004571000A patent/JP2006515862A/ja not_active Ceased
- 2003-12-03 WO PCT/US2003/038444 patent/WO2004050036A2/en not_active Ceased
- 2003-12-03 EP EP03787253A patent/EP1567520B1/en not_active Expired - Lifetime
- 2003-12-03 US US10/537,034 patent/US7491714B2/en not_active Expired - Fee Related
- 2003-12-03 DE DE60324179T patent/DE60324179D1/de not_active Expired - Lifetime
- 2003-12-03 ES ES03787253T patent/ES2312839T3/es not_active Expired - Lifetime
- 2003-12-03 AT AT03787253T patent/ATE411312T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515862A5 (https=) | ||
| JP2008505920A5 (https=) | ||
| JP2005525324A5 (https=) | ||
| RU2501799C2 (ru) | Поизводные оксазолидинона | |
| JP2004534780A5 (https=) | ||
| JP2005538125A5 (https=) | ||
| RU2007147413A (ru) | Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью | |
| JP2008506695A5 (https=) | ||
| JP2005519922A5 (https=) | ||
| RU2398769C2 (ru) | Азотосодержащие гетеробициклические соединения | |
| RU2506263C2 (ru) | Производные оксазолидиновых антибиотиков | |
| JP2004518661A5 (https=) | ||
| JP2005504747A5 (https=) | ||
| JP4704755B2 (ja) | 抗菌剤 | |
| WO2021161230A4 (en) | Small molecule sting antagonists | |
| JP2010523645A5 (https=) | ||
| RU2014123109A (ru) | Антибиотические производные 2-оксо-оксазолидин-3, 5-диила | |
| JP2004520360A5 (https=) | ||
| JP2006505505A5 (https=) | ||
| RU2010138648A (ru) | Азатрициклические соединения антибиотиков | |
| RU2406723C2 (ru) | ПРОИЗВОДНЫЕ 7-(2-АМИНО-1-ГИДРОКСИ-ЭТИЛ)-4-ГИДРОКСИБЕНЗОТИАЗОЛ-2(3Н)-ОНА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ | |
| PE20090370A1 (es) | Derivados de heterociclo fusionado como inhibidores de quinasa | |
| JP2005539087A5 (https=) | ||
| PE20120031A1 (es) | Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 | |
| JP2008505926A5 (https=) |